Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance.

Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance. BJU Int. 2014 Aug; 114(2):229-35.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.